Imperative Care, a Campbell, CA-based medical technology company, announced the initial close of its Series E funding for up to $150M.
The round was led by Ally Bridge Group with participation from other existing investors, including D1 Capital Partners, AMED Ventures, Bain Capital Life Sciences, Rock Springs Capital Management LP, Innovatus Capital Partners, LLC and Pura Vida Investments. The financing also included participation from new investors, including Catalio Capital Management, LP, HealthCor Family Office, Montreux Growth Partners, and INTAI Technology Corp.
The company intends to use the funds to expand operations and its development efforts.
Led by CEO Fred Khosravi, Imperative Care is a commercial-stage medical technology company researching and developing connected innovations to elevate care for people affected by devastating vascular diseases such as stroke and pulmonary embolism. It is focused on addressing specific gaps in treatment and care to make an impact across the entire patient journey.
The company also announced the appointment of Shacey Petrovic to the newly created position of Vice Chair of its Board of Directors.
Commenting on the news, Fred Khosravi said: “This latest financing fuels our hypergrowth strategy as we work to make better care accessible to more patients. We will continue to invest in novel technologies and clinical evidence to measure the impact of these technologies on patient outcomes.”
FinSMEs
25/07/2024